Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02957149 · ClinicalTrials.gov registry record · NA
Platelet Rich Plasma During Radical Prostatectomy
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02957149: Completed NA study, sponsored by Mayo Clinic.
NCT02957149 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02957149, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Can platelet rich plasma applied to nerve bundles at time of surgery help the nerve bundles heal? Subjects undergoing a Radical Prostatectomy who meet study inclusion/exclusion criteria will be consented to receive an intraoperative application of platelet-rich plasma, made from their own blood at the time of surgery, for application onto their neurovascular bundles in an effort to improve the healing process. Subjects will be followed for an additional 18 months to determine the efficacy and safety of this procedure.
Interventions
- OTHER Autologous Platelet-Rich Plasma
- DEVICE Angel Concentrated Platelet Rich Plasma System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-12 |
| Est. Completion | 2022-12-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02957149
The ClinicalTrials.gov registry entry for NCT02957149 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Autologous Platelet-Rich Plasma is the first listed.
NCT02957149 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02957149 about?
NCT02957149 is a clinical study titled "Platelet Rich Plasma During Radical Prostatectomy". Can platelet rich plasma applied to nerve bundles at time of surgery help the nerve bundles heal? Subjects undergoing a Radical Prostatectomy who meet study inclusion/exclusion criteria will be consented to receive an intraoperative application of platelet-rich plasma, made from their own blood at t...
What is the current status of trial NCT02957149?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2016-12. Estimated completion is 2022-12-21.
What interventions are being tested in trial NCT02957149?
The interventions under investigation include: Autologous Platelet-Rich Plasma (OTHER), Angel Concentrated Platelet Rich Plasma System (DEVICE).
Who is sponsoring clinical trial NCT02957149?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.